"From mutations to small molecules: lessons learned from Protein Phosphatase 2A”

Monday, November 4

11:30 a.m.

DRUG Lobby Conference Room

Dr. Narla is the Division Chief of Genetic Medicine and an Associate Professor in the Department of Medicine at the University of Michigan.  His research interests are in the study of mechanisms that regulate oncogene and tumor suppressor function in human cancer.  Specifically, on understanding the mechanisms driving human cancer development and progression.